141 related articles for article (PubMed ID: 17490545)
1. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
Li XF; Chen Q; Ye YB; Fan LF; Chen MS; Li JY; Chen HQ; Chen SP; Zhou ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):160-4. PubMed ID: 17490545
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.
Konagai A; Yoshimura K; Hazama S; Yamamoto N; Aoki K; Ueno T; Fujioka M; Iijima H; Kato M; Uchida M; Wada T; Inoue M; Asao T; Fuse M; Wada S; Kuramasu A; Kamei R; Takeda S; Yamamoto S; Yoshino S; Oka M; Nagano H
Anticancer Res; 2017 Aug; 37(8):4093-4101. PubMed ID: 28739693
[TBL] [Abstract][Full Text] [Related]
4. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
Feng L; Ke N; Ye Z; Guo Y; Li S; Li Q; Li Y
Transplant Proc; 2009 Dec; 41(10):4332-9. PubMed ID: 20005394
[TBL] [Abstract][Full Text] [Related]
5. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
[TBL] [Abstract][Full Text] [Related]
6. Yisheng injection decreases the expression of H60 and RAE-1 genes in ischemic mice liver.
Cheng F; Feng L; Li S; Tan J; Cao L; He Y; Ye Z; Li Y
Transplant Proc; 2006 Sep; 38(7):2210-3. PubMed ID: 16980045
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.
Cerwenka A; O'Callaghan CA; Hamerman JA; Yadav R; Ajayi W; Roopenian DC; Joyce S; Lanier LL
J Immunol; 2002 Apr; 168(7):3131-4. PubMed ID: 11907062
[TBL] [Abstract][Full Text] [Related]
8. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
Ogasawara K; Benjamin J; Takaki R; Phillips JH; Lanier LL
Nat Immunol; 2005 Sep; 6(9):938-45. PubMed ID: 16086018
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells.
Chen GE; Wu H; Ma J; Chadban SJ; Sharland A
Nephrol Dial Transplant; 2011 Dec; 26(12):3873-81. PubMed ID: 21555390
[TBL] [Abstract][Full Text] [Related]
10. Ligands for murine NKG2D display heterogeneous binding behavior.
Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama W
Eur J Immunol; 2002 Mar; 32(3):597-605. PubMed ID: 11857333
[TBL] [Abstract][Full Text] [Related]
11. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.
Weinger JG; Plaisted WC; Maciejewski SM; Lanier LL; Walsh CM; Lane TE
Stem Cells; 2014 Oct; 32(10):2690-701. PubMed ID: 24898518
[TBL] [Abstract][Full Text] [Related]
12. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
Bui JD; Carayannopoulos LN; Lanier LL; Yokoyama WM; Schreiber RD
J Immunol; 2006 Jan; 176(2):905-13. PubMed ID: 16393975
[TBL] [Abstract][Full Text] [Related]
13. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney.
Feng L; Cheng F; Ye Z; Li S; He Y; Yao X; Tang Q; Li Y
Transplant Proc; 2006 Sep; 38(7):2195-8. PubMed ID: 16980040
[TBL] [Abstract][Full Text] [Related]
14. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
Nature; 2001 Sep; 413(6852):165-71. PubMed ID: 11557981
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
Cerwenka A; Bakker AB; McClanahan T; Wagner J; Wu J; Phillips JH; Lanier LL
Immunity; 2000 Jun; 12(6):721-7. PubMed ID: 10894171
[TBL] [Abstract][Full Text] [Related]
17. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
18. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
[TBL] [Abstract][Full Text] [Related]
19. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
20. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
